All lobbying filings

DLA PIPER LLP (US)

Lobbying for INDIVIOR INC. · Pharmaceutical company

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Government bodies contacted 1

SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 2586
Reentry Act of 2025

Lobbying activity 2

Medicare/Medicaid

H.R. 2586, Reentry Act of 2025, policies related to reimbursement of substance use disorder treatment.

Health Issues

General education on issues related to the Drug Enforcement Agency (DEA). Issues related to substance use addiction and treatment, including NIH/HHS funding levels.Issues related to access to addiction treatments, including telehealth.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.